stockportfolio.pro
Stocks / BTSG vs MDGL
BTSG vs MDGL
BrightSpring Health Services, Inc. and Madrigal Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
BTSG is the larger company ($12.0B vs $11.0B). On the fundamentals, BTSG earns a higher net margin (1.5% vs -30.1%); BTSG has the stronger return on equity (10.2% vs -47.8%). Full numbers below — the stronger figure on each row is in green.
| BrightSpring Health Services, Inc. (BTSG) | Madrigal Pharmaceuticals, Inc. (MDGL) | |
|---|---|---|
| Market cap | $12.0B | $11.0B |
| Revenue (latest FY) | $12.91B | $958.40M |
| Net income (latest FY) | $190.67M | $-288.28M |
| Revenue growth (5y CAGR) | 18.7% | — |
| Net margin | 1.5% | -30.1% |
| Return on equity | 10.2% | -47.8% |
| P/E ratio | 79.3 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full BTSG vs MDGL breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BTSG's full financials → Open MDGL's full financials →More comparisons
Frequently asked questions
Which is bigger, BTSG or MDGL?
BrightSpring Health Services, Inc. is larger by market capitalization — $12.0B versus $11.0B.
Which grows faster, BTSG or MDGL?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
BTSG fundamentals → · MDGL fundamentals → · All 1,500+ companies → · Free screener →